← back to search

Timothy B. Erickson

University of Illinois Chicago · US
Area of research
Emergency Medicine · Toxicology
Research interest
Research interests include Wastewater, Coronavirus disease 2019 (COVID-19), Pandemic, Medicine, Population, and Sewage treatment.
h-index
citations
1,945
works
14
NIH funding
primary concept
email

Recent publications

The environmental health impacts of Russia’s war on Ukraine
Journal of Occupational Medicine and Toxicology 2024cited by 92position: lastdoi
Beta-blocker and calcium-channel blocker toxicity: current evidence on evaluation and management
European Heart Journal Acute Cardiovascular Care 2023cited by 12position: middledoi
Metrics to relate COVID-19 wastewater data to clinical testing dynamics
Water Research 2022cited by 119position: middledoi
Nationwide Trends in COVID-19 Cases and SARS-CoV-2 RNA Wastewater Concentrations in the United States
ACS ES&T Water 2022cited by 97position: middledoi
The New Humanitarian Crisis in Ukraine: Coping With the Public Health Impact of Hybrid Warfare, Mass Migration, and Mental Health Trauma
Disaster Medicine and Public Health Preparedness 2022cited by 46position: lastdoi
Wartime toxicology: the spectre of chemical and radiological warfare in Ukraine
Toxicology Communications 2022cited by 20position: lastdoi
United States and United Nations pesticide policies: Environmental violence against the Yaqui indigenous nation
The Lancet Regional Health - Americas 2022cited by 12position: middledoi
SARS-CoV-2 RNA concentrations in wastewater foreshadow dynamics and clinical presentation of new COVID-19 cases
The Science of The Total Environment 2021cited by 302position: middledoi
Wastewater surveillance of SARS-CoV-2 across 40 U.S. states from February to June 2020
Water Research 2021cited by 179position: middledoi
“Waste Not, Want Not” — Leveraging Sewer Systems and Wastewater-Based Epidemiology for Drug Use Trends and Pharmaceutical Monitoring
Journal of Medical Toxicology 2021cited by 51position: firstdoi
Wastewater network infrastructure in public health: Applications and learnings from the COVID-19 pandemic
PLOS Global Public Health 2021cited by 47position: lastdoi
Analysis of 39 drugs and metabolites, including 8 glucuronide conjugates, in an upstream wastewater network via HPLC-MS/MS
Journal of Chromatography B 2021cited by 27position: middledoi
SARS-CoV-2 Titers in Wastewater Are Higher than Expected from Clinically Confirmed Cases
mSystems 2020cited by 875position: middledoi
Mapping Community Opioid Exposure Through Wastewater-Based Epidemiology as a Means to Engage Pharmacies in Harm Reduction Efforts
Preventing Chronic Disease 2020cited by 66position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Claire Duvallet · Massachusetts Institute of Technology8 papers (2020–2022)Mariana Matus · Massachusetts Institute of Technology8 papers (2020–2022)Noriko Endo · Massachusetts Institute of Technology7 papers (2020–2022) · 6 papers (2020–2022)Eric J. Alm · Amgen (United States)6 papers (2020–2022)Peter R. Chai · University of Colorado Denver5 papers (2020–2022)Peter R. Chai · Broad Institute5 papers (2021–2023)Fuqing Wu · Massachusetts Institute of Technology4 papers (2020–2022)Jianbo Zhang · Massachusetts Institute of Technology4 papers (2020–2022)Amy Xiao · Boston University4 papers (2020–2022)William P. Hanage · Harvard University3 papers (2020–2022)Janelle R. Thompson · Massachusetts Institute of Technology3 papers (2020–2022) · 3 papers (2021–2022)Federica Armas · National University of Singapore3 papers (2020–2022)Wei Lin Lee · National University of Singapore3 papers (2020–2022)Katya Moniz · Massachusetts Institute of Technology3 papers (2020–2022)Xiaoqiong Gu · National University of Singapore3 papers (2020–2022) · 2 papers (2021–2021)Mary Bushman · Center for Disease Dynamics, Economics & Policy2 papers (2021–2022)Scott W. Olesen · Università degli studi di Cassino e del Lazio Meridionale2 papers (2021–2022)